Celebrating Women and Girls in Science Day, February 11
Today, February 11th, we recognize the role of women and girls in science, not only as beneficiaries, but also as agents of change, including in view of accelerating progress towards …
New NCI FOA supports the development of cancer-relevant technologies for use in LMICs
NOT-CA-22-031 Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) The purpose of this announcement …
A highly virulent variant of HIV-1 circulating in the Netherlands
Our recent experiences with the coronavirus pandemic have demonstrated that new mutations in viral genetic sequences can have significant impacts on the virus’s transmissibility and the degrees of illness it …
World Cancer Day is on February 4. The time to act is now.
World Cancer Day, observed on February 4th, annually, is the global uniting initiative led by the Union for International Cancer Control (UICC). By raising worldwide awareness, improving education, advocatitng for …
Reignighting Cancer Moonshot to End Cancer As We Know It
Today, February 2nd, President Biden is renewing his committment to the Cancer Moonshot initiative. The Biden-Harris administration will dedicate funding and resources to reduce the death rate from cancer by at least …
New research suggests Pembrolizumab could help flush HIV from its hiding spots
How do HIV/AIDS & cancer research continue to converge? Read more about the early results from a novel study which shows that pembrolizumab, a cancer drug, can flush HIV from …
Symposium: Maximizing the Research Use of Small Biopsy Tissue
The National Cancer Institute’s Cancer Moonshot(SM) Biobank will be hosting a mini-symposium on “Maximizing the Research Use of Small Biopsy Tissue” on Wednesday, February 9th from 9AM-12 PM EST. This …
New NCI FOA U.S. and Low- and Middle-Income Country HIV-Associated Malignancy Research Centers
RFA-CA-22-001, U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trial Optional) has been published. This is a reissuance of RFA-CA-20-001. The purpose of this Funding Opportunity Announcement …
Plasma EBV DNA: A Promising Diagnostic Marker for Endemic Burkitt Lymphoma
As 2021 comes to a close, we celebrate some important work published by our colleagues (Ambinder, et al) who dedicate their careers to improving diagnosis, treatment and outcomes for people …
50th Anniversary of the National Cancer Act
Yesterday, the White House issued a proclamation to recognize today’s 50th anniversary of President Nixon’s signing of the National Cancer Act, recommitting to the investment in people and science to …